Log in to save to my catalogue

Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS):...

Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS):...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2576872675

Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery

About this item

Full title

Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery

Publisher

England: Elsevier Ltd

Journal title

The lancet oncology, 2021-10, Vol.22 (10), p.1448-1457

Language

English

Formats

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

SummaryBackgroundA previous pooled analysis of the STARS and ROSEL trials showed higher survival after stereotactic ablative radiotherapy (SABR) than with surgery for operable early-stage non-small-cell lung cancer (NSCLC), but that analysis had notable limitations. This study reports long-term results of the revised STARS trial, in which the SABR...

Alternative Titles

Full title

Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2576872675

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2576872675

Other Identifiers

ISSN

1470-2045

E-ISSN

1474-5488

DOI

10.1016/S1470-2045(21)00401-0

How to access this item